Kortex Ventures

Kortex Ventures is a global venture capital fund established in 2020 and based in Brazil, focusing primarily on early-stage companies in the health tech and healthcare technology sectors. The firm seeks to collaborate with exceptional entrepreneurs and innovative organizations to advance the future of healthcare through technological solutions. By investing in promising startups, Kortex Ventures aims to drive meaningful change within the healthcare landscape.

Hans Lenk

Managing Director

9 past transactions

Caveo

Seed Round in 2025
Caveo is a digital platform that provides financial and accounting solutions tailored to medical practitioners. Its platform automates administrative tasks, enabling doctors to manage their earnings, expenses, invoices, taxes, and reports efficiently.

Welbe

Series A in 2024
Welbe Care is a healthcare platform developer based in Mexico City, established in June 2021 by Eduardo Medeiros Cardoso, Eduardo Medeiros, and Marcus Paiva. The company focuses on managing workers' health through the integration of data collection and artificial intelligence. Its platform creates a comprehensive health ecosystem that connects with local health services, including laboratories, clinics, and insurers. This integration allows businesses to monitor employee health effectively, identify potential issues, and enhance both productivity and quality of life. Additionally, Welbe Care offers an intelligent occupational management system paired with a minor medical expenses program that eliminates deductibles and copayments, further supporting the well-being of employees.

Biologix

Venture Round in 2024
Biologix is a healthcare technology company that specializes in sleep diagnostics. It offers a Software as a Service (SaaS) platform and medical devices, enabling healthcare professionals to provide their patients with a convenient, affordable, and accurate sleep test for obstructive sleep apnea. The company's innovative solution combines a compact, wireless sensor with a smartphone, simplifying the process of diagnosing snoring and sleep-disordered breathing.

SiPhox Health

Series A in 2023
SiPhox Health, based in Cambridge, Massachusetts, specializes in designing and manufacturing innovative diagnostic solutions. The company develops next-generation diagnostics infrastructure, including at-home test kits and central lab systems. Their flagship product is a disposable biosensor cartridge that assesses 17 blood biomarkers, providing insights into inflammation, hormonal health, metabolic fitness, and cardiovascular health. SiPhox Health's platform merges biochemistry, photonic chip technology, integrated photonics, electronics, and microfluidics to enable sensitive readouts of immunoassays and nucleic acid tests, facilitating point-of-need and at-home diagnostics.

Welbe

Seed Round in 2022
Welbe Care is a healthcare platform developer based in Mexico City, established in June 2021 by Eduardo Medeiros Cardoso, Eduardo Medeiros, and Marcus Paiva. The company focuses on managing workers' health through the integration of data collection and artificial intelligence. Its platform creates a comprehensive health ecosystem that connects with local health services, including laboratories, clinics, and insurers. This integration allows businesses to monitor employee health effectively, identify potential issues, and enhance both productivity and quality of life. Additionally, Welbe Care offers an intelligent occupational management system paired with a minor medical expenses program that eliminates deductibles and copayments, further supporting the well-being of employees.

NeuralMed

Venture Round in 2022
NeuralMed is a healthcare startup that leverages artificial intelligence to analyze unstructured data from diverse sources, creating a comprehensive and secure data matrix. The company focuses on developing innovative solutions that utilize proprietary algorithms to optimize real-time medical data for healthcare institutions. These algorithms enhance patient flow organization by criticality and support healthcare professionals in diagnosing conditions through the analysis of medical images and free-text reports. NeuralMed's technology is designed for seamless integration into existing systems, ensuring reliability and higher user adherence. By streamlining screening and decision-making processes, NeuralMed aims to improve diagnostic accuracy while reducing costs for healthcare providers.

ISA Saúde

Series A in 2022
ISA is a digital-first home healthcare provider harnessing technology to bring care directly to patients' home, providing higher quality services at a fraction of the cost. Currently, ISA offers outpatient care, lab work services and immunizations. We are aiming to be the largest non-hospital healthcare company in Latam, by providing access to affordable healthcare services for millions of people through the decentralization of care.

Huna

Pre Seed Round in 2022
We are committed to making early cancer detection faster, cheaper and accessible

Sweetch

Series A in 2021
Sweetch is a behavioral science company that utilizes artificial intelligence and emotional intelligence to provide digital therapeutic solutions. The company has developed a hyper-personalized engagement platform designed to enhance clinical outcomes for individuals with chronic conditions. This platform offers tailored recommendations that consider the right timing, tone, and real-world context, guiding patients throughout their health journey. By catering to the specific needs of patients, Sweetch enables pharmaceutical companies, device manufacturers, payers, and healthcare providers to establish continuous relationships and effectively engage with each individual at scale.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.